However, when the manufacturer, Novo Nordisk, discovered it also carried significant weight loss effects, it introduced the higher dose version, Wegovy, which is approved as a diet drug
Clinical studies have shown it can improve vaccine responses, reduce infections in immunocompromised patients, and even aid recovery in sepsis or severe viral illnesses
In some of the mentioned disease cases, other properties of the NL-GHK-Cu peptide also contribute to defining it as a supportive factor in preventive therapy, allowing for the inhibition or reduction of the risk of diseases of various origins
The locomotor activity was assessed as count per 5 m (Ayoub et al
As a result, researchers are evaluating alternative sources for research compounds